What are bispecific antibodies, how do they work, and how are they changing blood cancer treatment? Find out in this virtual lecture where Dr. Bilal Abid of Texas Tech University Health Sciences Center explains how these therapies help the immune system target cancer cells, who may benefit from this treatment, and what patients can expect during treatment. The discussion also covers side effects, daily life considerations, and how bispecific antibodies compare to other options like CAR T-cell therapy, helping patients and caregivers feel more informed and confident
Bispecific antibodies explained for blood cancers
We hope you find this webcast informative and helpful. We would really appreciate your feedback, which helps us to plan future videos and resources.
Topics
- What bispecific antibodies are and how they work
- Who may benefit from this type of treatment
- Common side effects and how they are managed
- What to expect during treatment and follow-up care
Program Materials
Speaker
M. Bilal Abid, MD, MS, FACP, MRCP, FRCP
Associate Professor of Medicine
Medical Director, Cellular Immunotherapy and Blood & Marrow Transplant
UMC Cancer Center
Texas Tech University Health Sciences Center
Lubbock, TX
Support
This program is supported by Johnson & Johnson.